Originally published In Press as doi:10.1074/jbc.M111625200 on February 4, 2002
J. Biol. Chem., Vol. 277, Issue 16, 14306-14314, April 19, 2002
Evolutionary Relationship between Different Subgroups of
Restriction Endonucleases*
Vera
Pingoud
§,
Elena
Kubareva¶,
Gudrun
Stengel
,
Peter
Friedhoff
,
Janusz M.
Bujnicki
,
Claus
Urbanke**,
Anna
Sudina¶, and
Alfred
Pingoud
From the
Institut für Biochemie,
Justus-Liebig-Universität, Heinrich-Buff-Ring 58, D-35392 Giessen, Germany, ¶ A. N. Belozersky Institute,
Physicochemical Biology and Chemistry Department, Moscow State
University, Moscow 119899, Russia,
Bioinformatics Laboratory,
International Institute of Molecular and Cell Biology, 4 Ks.
Trojdena, 02-109 Warsaw, Poland, and
** Biophysikalisch-Biochemische Verfahren, Medizinische
Hochschule Hannover, Carl-Neuberg-Strasse 1, D-30623 Hannover, Germany
Received for publication, December 6, 2001, and in revised form, February 1, 2002
 |
ABSTRACT |
The type II restriction endonuclease
SsoII shows sequence similarity with 10 other restriction
endonucleases, among them the type IIE restriction endonuclease
EcoRII, which requires binding to an effector site for
efficient DNA cleavage, and the type IIF restriction endonuclease
NgoMIV, which is active as a homotetramer and cleaves DNA
with two recognition sites in a concerted reaction. We show here that
SsoII is an orthodox type II enzyme, which is active as a
homodimer and does not require activation by binding to an effector
site. Nevertheless, it shares with EcoRII and
NgoMIV a very similar DNA-binding site and catalytic center
as shown here by a mutational analysis, indicative of an evolutionary
relationship between these three enzymes. We suggest that a similar
relationship exists between other orthodox type II, type IIE, and type
IIF restriction endonucleases. This may explain why similarities may be
more pronounced between members of different subtypes of restriction enzymes than among the members of a given subtype.
 |
INTRODUCTION |
More than 3000 different type II restriction endonucleases are
known and characterized with respect to their cleavage specificities (1). This group of enzymes probably constitutes one of the largest
families of enzymes with the same basic function. This makes type II
restriction endonucleases (like DNA methyltransferases) ideal objects
to study evolutionary relationships. Moreover, in principle, the family
relationships should eventually allow predicting structural and
functional features of an individual restriction endonuclease, solely
on the basis of sequence comparisons. This was not obvious for a long
time since only 10 years ago restriction endonucleases, because of
their little sequence conservation, were not considered to be related
in evolution (2, 3). But this changed due to the progress made in the
analysis of sequence similarities (4-6) and, in particular, due to the
increasing number of crystal structures of restriction enzymes
(reviewed in Refs. 7 and 8), which made it obvious that these enzymes have very similar structural cores. Nevertheless, it has been shown
recently that some genuine restriction enzymes belong to distinct
nuclease superfamilies (Nuc, HNH, and GIY-YIG), which are unrelated and
structurally dissimilar to each other and to the "archetypal"
(P)D ... (D/E)XK superfamily (9-11). These findings make comparative studies using sequences of restriction enzymes even
more challenging.
We have begun to study the restriction endonuclease SsoII
recently (12-15). It is a type II enzyme (reviewed in Refs. 8 and 16)
composed of identical subunits each consisting of 305 amino acid
residues (17). It cleaves the palindromic sequence
CCNGG in the
presence of Mg2+ as indicated (18). Our interest in
studying this enzyme is due to its sequence similarity to
EcoRII, a type IIE enzyme (reviewed in Ref. 19), which being
somewhat larger than SsoII is a dimer of identical subunits
each consisting of 404 amino acid residues (20, 21). As a type IIE
enzyme EcoRII has two DNA-binding sites, one associated with
the catalytic center and the other serving as an effector site (22)
(which has led to the acronym type IIE) (23-25), similar to that shown
for NaeI (26-29). The recognition sequence of
EcoRII is
CCWGG (30), which means that SsoII
and EcoRII can be considered to be quasi isoschizomers.
Thus, these two enzymes have a similar "genotype" (amino acid
sequence) and "phenotype" (recognition sequence) which suggest a
relatively close evolutionary relationship (4).
Sequence similarities between SsoII and EcoRII
were first noticed by Morgan et al. (31). They had
determined the sequence of PspGI, an isoschizomer of
EcoRII, which is more similar in size (each subunit
comprising 272 amino acid residues) and sequence to SsoII
than to EcoRII. Morgan et al. (31) identified a
conserved segment of 87 amino acid residues in these three enzymes and
proposed that this segment is part of a common DNA recognition domain
for CCXGG sequences. The significance of sequence
similarities between SsoII and EcoRII was
emphasized by Reuter et al. (32), who had identified by a
peptide scanning technique two DNA-binding sites in EcoRII,
one of which showed a highly significant similarity to SsoII
(consisting of the sequence R(R/K)SRAGKXXE (DNA-binding site
II)). The importance of the underlined lysine residues of the
R(R/K)SRAGKXXE motif for the
function of EcoRII was demonstrated by a mutational analysis
as follows: the K263A/K268A and K263E/K268E variants were active in
specific DNA binding but inactive in DNA cleavage (32). In this study
another DNA-binding site (DNA-binding site I) was identified, located
in the N-terminal domain of EcoRII, not present in
SsoII and PspGI, and it was proposed that this DNA-binding site is associated with a potential catalytic center. The
importance of this binding site for the function of EcoRII was again demonstrated by a mutational analysis as follows: the K92A/K97A and K92E/K97E variants were severely impaired in DNA binding
but were more or less active; the E96A variant, in contrast, was
inactive in DNA cleavage. It was speculated by Reuter et al. (32) that Glu-96 is part of a variant PD ... (D/E)XK
motif, characteristic for the catalytic center of many type II
restriction endonucleases (33-35), with the last lysine replaced by
arginine. It is noteworthy that the sequence alignment given by Morgan
et al. (31) for PspGI, SsoII, and
EcoRII extends into a region that contains a potential
(P)D ... (S)XK ... (D/E) motif, identified as the
catalytic motif in the type IIF restriction endonucleases
Cfr10I (36-38) and NgoMIV (39). The significance
of this homology, however, was not realized by Morgan et al.
(31). The (P)D ... (S)XK ... (D/E) sequence could
represent the catalytic center not only of SsoII and
PspGI but also of EcoRII. This would imply that
DNA-binding site I identified by Reuter et al. (32) is the
effector site and not the catalytic center.
The goal of this study was to identify amino acid residues involved in
DNA recognition and cleavage by SsoII. Based on sequence alignments and structural comparisons and verified by a mutational analysis, we have identified two regions that are essential for the
function of SsoII, one of which is very likely to harbor the catalytic center. The sequences characterizing these regions are present in several other orthodox type II as well as type IIE enzymes
(which require binding of a substrate at the active site and the
effector site) and IIF enzymes (which require binding of a substrate at
two active sites formed by four identical subunits) that recognize
CCGG, CCNGG, or CCWGG in different sequence contexts, an observation
that has implications for the evolution of these subtypes of type II
restriction endonucleases.
 |
EXPERIMENTAL PROCEDURES |
Site-directed Mutagenesis of SsoII Variants--
Site-directed
mutagenesis of the SsoII gene was performed by a PCR-based
technique (40). The mutant genes were sequenced and found to contain
only the mutation desired.
Protein Expression and Purification--
The SsoII
overproducing strain was kindly provided by Dr. A. Karyagina (Institute
of Agricultural Biotechnology, Moscow, Russia). SsoII and
its variants were expressed in Escherichia coli JM109 and
purified to homogeneity as described by Sheflyan et al.
(14).
Analytical Ultracentrifugation Experiments--
Analytical
ultracentrifugation was done in a Beckman XL-A Analytical
Ultracentrifuge equipped with a photoelectric scanner. All experiments
were done at 4 °C in 10 mM Tris/HCl, pH 8.0, 50 mM NaCl.
Sedimentation velocity experiments were done in an 8-place An50 Ti
rotor with double sector centerpieces made of charcoal filled Epon at
45,000 rpm.
To evaluate binding of double-stranded
d(GCTGCCAACCTGGGTCTAAC) (US/LS-20a) to
SsoII the concentrations of free and bound
oligo1 US/LS-20a were
extracted from the measured profiles
A(x,t) by fitting Equation 1,
|
(Eq. 1)
|
where xm is position of the meniscus;
Ai(xm,0) is absorption of the
ith sedimenting boundary at the beginning of the experiment;
si is sedimentation coefficient of the
ith sedimenting boundary;
k is a parameter
describing the width of each measured sedimentation profile;
is
angular velocity of the rotor. This fit corresponds to a description of
the sedimenting boundaries by a Gaussian error function and yields the
absorption for free oligo US/LS-20a and the sum of the absorptions for
total SsoII and bound oligo US/LS-20a at the beginning of
the sedimentation run.
For sedimentation equilibrium analysis samples of 120 µl were run in
6-channel centerpieces (column height ~3 mm) at the specified speed
until no change in concentration distribution could be observed for at
least 12 h. Scans from these 12 h were averaged to reduce random noise.
A simple aggregation model will describe the association of
n dimers of SsoII to form a single aggregate. For
such a reaction the law of mass action can be written as Equation 2,
|
(Eq. 2)
|
with SsoIIn being the n-mer
aggregate and Kagg the bimolecular equilibrium
constant for aggregation.
For evaluation of the sedimentation equilibrium the distribution of
each species is calculated by numerically solving
|
(Eq. 3)
|
x(xm), radial position (of
the meniscus), and
i, partial specific volume of
the ith species, where all ci(x) must obey the above law of mass
action. The partial specific volume for SsoII was calculated
from the amino acid composition to be 7.25 × 10
4
m3/kg.
Gel Filtration--
Gel filtration experiments were performed at
room temperature on a Merck-Hitachi system using a Superdex 75 column
(Amersham Biosciences), equilibrated with 25 mM Tris/HCl,
pH 8.0, 100 mM NaCl, 10 mM CaCl2.
Free SsoII or SsoII in complex with oligo
US/LS-20a were diluted in the same buffer and loaded onto the column.
Chromatography was carried out at a flow rate of 1 ml/min at 20 °C.
Elution was monitored by absorbance at 280 nm. The molar masses were
determined by interpolation, using a calibration curve of proteins of
known molar mass (molecular weight marker kit, Sigma).
Circular Dichroism Spectroscopy--
Circular dichroism spectra
were recorded in 10 mM Tris, 50 mM NaCl in a
Jasco J-710 dichrograph at 20 °C in a cylindrical cuvette of 0.05-cm
path length.
DNA Cleavage Assay--
The DNA cleavage activities of wild type
SsoII and the mutants were determined by performing cleavage
experiments in cleavage buffer (10 mM Tris/HCl, pH 7.5, 50 mM NaCl, 1 mM dithiothreitol, 10 mM
MgCl2, 0.1 mg/ml bovine serum albumin) at 37 °C with
32P-labeled PCR products as substrate.
Cleavage experiments designed to compare the rates of cleavage of one-
and two-site substrates by wild type SsoII were performed with two different PCR products containing one recognition sequence each with a different flanking base pair
(GCCTGGG (325 bp) and CCCTGGG (221 bp)) and one PCR product
containing both recognition sites (442 bp). Cleavage experiments that
were carried out to determine the activity of the SsoII
variants were carried out with the 325-bp substrate. After incubation
for a specified time, reaction products were analyzed by
electrophoresis on 10% polyacrylamide gels. The gels were subsequently
subjected to autoradiography using an instant imager (Packard
Instrument Co.).
Electrophoretic Mobility Shift Assay--
For electrophoretic
mobility shift assays SsoII and the respective variants were
mixed with binding buffer (10 mM Tris/HCl, pH 8.5, 100 mM NaCl, 5 mM CaCl2, 0.1 mg/ml
bovine serum albumin, 10% (v/v) glycerol) in a total volume of 10 µl
in addition containing 0.1 µg of poly(dI-dC) (Amersham Biosciences)
and 32P-labeled double-stranded
d(GCTGCCACCCTGGGTCTAAC), oligo US/LS-20b. After
incubation for 30 min at 20 °C, the samples were applied to a 12%
polyacrylamide gel. After electrophoresis for 5 h at 80 V (10 V/cm) in 20 mM Tris acetate, pH 8.5, 5 mM
CaCl2, gels were subjected to autoradiography using an
instant imager (Packard Instrument Co.).
Sequence Analysis and Structure Prediction--
The multiple
alignment was obtained based on PSI-BLAST searches of the non-redundant
sequence data base at the NCBI (www.ncbi.nlm.nih.gov) and edited
manually based on consensus secondary structure prediction and
threading results reported by the Meta Server (41, 42) with the links
to the individual methods provided therein and at the website
bioinfo.pl/meta/. The alignment of NgoMIV and
Cfr10I was based on the structural superposition of the
atomic coordinates. The neighbor-joining tree (43) was estimated from
100 bootstrap resamplings of the conserved alignment.
Homology modeling of the core region (residues 115-257) of
SsoII was performed using Swiss-PdbViewer and Swiss model
(44) based on the coordinates of the NgoMIV-product complex
(39). A series of alternative models of the SsoII monomer
were submitted to the Verify3D server (45) to evaluate compatibility of
the residues with the environment. The best structure was used to model
the interactions of SsoII with the cleaved target DNA. At the outset, the coordinates of the double-stranded d(GCGCCGGCGC) containing the NgoMIV target sequence were copied to the
model from the template structure. Subsequently, the
SsoII-DNA complex was duplicated and positioned in such a
way that one of the subunits remained superimposed onto the
corresponding NgoMIV monomer, whereas the other was shifted
and rotated to reflect insertion of 1 bp in the middle of the DNA
sequence. It was immediately recognized that preservation of the
NgoMIV-like structure of the DNA and orientation of the
active sites in respect to the "CC" element in both
SsoII monomers lead to unresolvable steric clashes and loss
of contact of Arg-186 and Arg-188 side chains with the "GG" element. Thus, the 185-189 loop of SsoII was separately
superimposed onto the 190-195 loop of NgoMIV to mimic its
interaction with the "GG" element. Subsequently, the two subunits
were mutually rotated together with the DNA to reduce the overlap at
the dimer interface and to bring the ends of the displaced 185-189
loop close enough to the original attachment points to allow
reconnection of the polypeptide backbone without distortion of the
neighboring regions. As an outcome, the model of the
SsoII-DNA complex contains two regions of interaction with
the CC and the GG elements that closely resemble those of the
NgoMIV template structure but which could not be
simultaneously superimposed onto it. The final model of the monomer was
refined using GROMOS (46), duplicated, and docked onto the DNA created
from two NgoMIV half-sites "GCGCC" with an additional AT
base pair manually inserted in the middle.
 |
RESULTS |
We show here that SsoII shares sequence similarities
with EcoRII, Cfr10I, and NgoMIV (among
others). The most interesting aspect of this is that EcoRII,
Cfr10I, and NgoMIV require simultaneous binding
of two substrates (or one substrate with two recognition sites) for
efficient cleavage. Whereas EcoRII is a type IIE enzyme, which are homodimeric proteins with two distinct binding sites for
their respective recognition sequences, one being the active site and
the other the effector site, Cfr10I and NgoMIV
are type IIF enzymes, which are composed of four identical subunits
that form two active sites which in a coordinate manner cleave the two
recognition sites (47). In order to characterize the relationship between SsoII and the type IIE (EcoRII) and type
IIF (Cfr10I and NgoMIV) enzymes, it had to be
investigated to what subtype of type II restriction endonucleases
SsoII belongs and to find out whether the sequence
similarities between SsoII on one hand and type IIE and IIF
enzymes on the other hand concern functionally important residues.
Analytical Ultracentrifugation and Gel Filtration
Experiments--
Orthodox type II restriction enzymes are homodimeric
enzymes. The quaternary structure of SsoII is not known. In
order to determine the native molar mass of SsoII,
analytical ultracentrifugation and gel filtration experiments were
carried out.
Sedimentation velocity runs with free SsoII showed that most
of the protein (>80%) sedimented with 5 S. Because the largest sedimentation coefficient for a protein with a mass of 35.9 kDa is 3.77 S, the value of 5 S shows that the predominant form of SsoII is a dimer. A minor component (<20%) sedimented with
~20 S indicating the presence of larger aggregates (data not shown).
Fig. 1A shows the result of a
sedimentation equilibrium experiment with SsoII. Assuming an
aggregation equilibrium, the concentration profile can best be
described by a reaction of dimers, the predominant species at
micromolar concentrations, interacting in a
concentration-dependent manner with each other to form an
aggregate consisting of ~14 dimers, with a bimolecular equilibrium
constant, Kagg, of 1 × 105
M
1 which would yield half of the dimer being
engaged in aggregates at a total concentration of 3 × 10
4 M. The presence of significant amounts of
monomers is incompatible with the measured protein concentration
profile as is an association of dimers forming only tetramers.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
Analytical ultracentrifugation.
A, sedimentation equilibrium of 6 µM
SsoII at 10,000 rpm ( ). The smooth line
represents a theoretical concentration profile and ( ) the
corresponding residuals for a SsoII dimer aggregating to
form a 14-mer aggregate with an equilibrium constant of 1 × 105 M 1. Note the different scale
for the residuals. B, sedimentation velocity experiment
with 2.5 µM SsoII dimer and 6.5 µM double-stranded d(GCTGCCAACCTGGGTCTAAC). Scans were
taken at an interval of 480 s. The smooth lines
represent theoretical concentration distributions calculated as a sum
of two Gaussians where the fast moving boundary contains 2.5 µM SsoII dimer and 2.1 µM
double-stranded eicosadeoxynucleotide indicating a 1:1
stoichiometry.
|
|
Fig. 1B shows the sedimentation profiles of a mixture of
SsoII and excess oligo US/LS-20a, a double-stranded
eicosadeoxynucleotide containing one recognition site in a central
position. From the evaluation of the absorption of the two sedimenting
boundaries a stoichiometry of one oligo US/LS-20a binding to one
SsoII dimer can be deduced.
Gel filtration on a Superdex 75 column showed that SsoII
coelutes with bovine serum albumin (66 kDa) indicating that the
quaternary structure of SsoII is that of a dimer (72 kDa).
In the presence of Ca2+ and an excess of oligo US/LS-20a,
the SsoII-DNA complex eluted with an apparent mass of
80 kDa, which is in good agreement with the calculated mass of 84 kDa
for the 1:1 complex (data not shown).
The results of the analytical ultracentrifugation and the gel
filtration experiments demonstrate that SsoII-like orthodox type II restriction endonucleases is a homodimer, both in the absence
and presence of DNA.
Our finding that SsoII is a homodimer is somewhat at
variance with a result obtained for a very close relative of
SsoII, namely Ecl18kI which differs only in one
position (position 232 where SsoII has an isoleucine and
Ecl18kI a valine residue) (48), based on a gel filtration
analysis Ecl18kI was identified to be a homotetramer (49).
Of course, it cannot be excluded that a valine for isoleucine
substitution could change a dimer to tetramer equilibrium.
Steady-state DNA Cleavage Experiments--
SsoII shows
sequence similarity to EcoRII, a typical type IIE
restriction endonuclease, which requires binding to two recognition sites for efficient cleavage (22). To find out whether SsoII behaves like a type IIE enzyme, DNA cleavage experiments were carried
out with substrates containing one or two sites. PCR products containing one (221- and 325-mer) or two sites (442-mer) are
cleaved with rates dependent on the sequence context,
CCCTGGG (kapp = 0.26 ± 0.03 min
1) is cleaved faster than
GCCTGGC (kapp = 0.15 ± 0.02 min
1), but independent of whether one
or two sites are present (Fig. 2).
Cleavage of the 325-mer (which contains only one site) could not be
stimulated in trans, as observed for EcoRII (50),
by addition of oligo US/LS-20a in concentrations varied from 0.5- to
5-fold excess; in contrast, with increasing concentration of the
oligodeoxynucleotide an inhibition of the cleavage of the 325-mer was
observed (data not shown). The cleavage of the 1-site and 2-site
substrates was investigated at different ionic strengths. With
increasing ionic strength (from 50 to 150 mM NaCl)
SsoII cleaves the substrates with one (221 bp, CCCTGGG) or
two recognition sites (442 bp, CCCTGGG and GCCTGGG) with reduced but
equal rates (data not shown). These results confirm that
SsoII, despite its sequence similarity to EcoRII,
is an orthodox type II enzyme.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Cleavage of radioactively labeled substrates
with one or two recognition sites by SsoII.
A, 100 nM PCR products containing either
one (221 bp, CCCTGGG, left; 325 bp,
-GCCTGGG-, right) or two recognition
sites (442 bp, CCCTGGG, and
GCCTGGG, middle) were incubated with
25 nM SsoII. Aliquots were withdrawn after 0, 2.5, 5, 7.5, 10, 15 and 20 min, respectively, and analyzed by
electrophoresis, followed by autoradiography using an instant imager.
B, disappearance of the two 1-site and the 2-site
substrates was evaluated quantitatively for the two 1-site substrates
(221 bp ( ) and 325 bp ( )) and the 2-site substrate (442 bp). It
is evident that the 2-site substrate (442 bp ( )) is cleaved as fast
as the 1-site substrate with the CCCTGGG
sequence (221 bp).
|
|
Alignment of the Sequence of SsoII with the Sequences of Other Type
II Restriction Endonucleases--
Sequence similarities between
SsoII (recognition sequence:
CCNGG, PspGI
(
CCWGG)), and EcoRII (
CCWGG) had been identified over
a stretch of ~90 amino acid residues (amino acid residues 108-196 in
SsoII) by Morgan et al. (31) leading to
speculations that this segment is part of a common DNA recognition
domain for CCXGG and should also be found in the amino acid
sequence of BstNI (CC
WGG), MvaI (CC
WGG),
and ScrFI (CC
NGG). Our inspection of the sequences of
ScrFI (51) and of
MvaI2 showed that
there is no significant similarity between these sequences and the
sequences of SsoII, PspGI, and EcoRII;
the sequence of BstNI is not yet available. On the other
hand, it was recently observed that eight different type II restriction
enzymes (including SsoII, PspGI,
EcoRII and among others NgoMIV, whose cocrystal structure is known), which all have recognition sites with adjacent guanine residues, harbor a
KX3RXXRX6E motif (8). The
cocrystal structure of NgoMIV indeed shows that the Arg-191
and Arg-194 residues recognize the guanines (underlined) of the
GCCGGC recognition sequence (39). We have now
systematically analyzed all available sequences of type II restriction
enzymes, including sequences of presumptive type II restriction enzymes
obtained in the course of genome sequencing projects, for sequence
similarity to SsoII. This analysis came up with 11 bona fide type II restriction enzymes (AccIII,
BsrFI, Cfr10I, EcoRII,
HpyAo263, Kpn2I, MjaVIP,
NgoMIV, PspGI, SgrAI, and
SsoII) and three presumptive type II restriction enzymes
(CteIP, DvuIP, and NmeAo1499) with
clustered regions of significant sequence similarity (Fig.
3). It was intriguing to note that the
recognition sequences of these enzymes all contain CCGG or CCNGG or
CCWGG, and furthermore that these enzymes belong to different subtypes,
viz. orthodox type II enzymes (like SsoII), type
IIE enzymes (like EcoRII), and type IIF enzymes (like
Cfr10I and NgoMIV).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 3.
Alignment of partial amino acid sequences of
SsoII and 13 other bona fide
(recognition sequence indicated) or presumptive type II
restriction endonucleases. Similar or identical amino acid
residues in the 14 sequences are indicated in gray or
black. Amino acid residues that were subjected to a
mutational analysis in SsoII are indicated on top of the
figure boxed (presumably involved in catalysis) or not
boxed (presumably involved in DNA binding); their position in the
SsoII sequence is indicated on top. The alignment
is subdivided in two groups: the top group consists of restriction
enzymes that recognize CCNGG or
CCWGG and the bottom group
CCGG.
|
|
We failed to detect a typical (P)D ... (D/E)XK motif,
which characterizes the active site of many type II restriction
endonucleases (6, 33-35), in the sequence of any of the endonucleases
represented in Fig. 3. However, we found a very well conserved
(P)D ... (S)XK ... (D/E) motif, which has been
shown first for Cfr10I to be a variant of the (P)D ...
(D/E)XK motif (37) and later identified as such in the
NgoMIV cocrystal structure (39). The (P)D ...
(S)XK ... (D/E) motif is 100% conserved in all the
sequences shown in the alignment, giving credence to the supposition
that it represents the active center not only in NgoMIV and
Cfr10I but also in the other enzymes. Between the
(presumptive) catalytic residues Lys (Lys-187 in
NgoMIV) and (Asp/Glu) (Glu-201 in NgoMIV), there
are three also 100% conserved (Arg/Lys) (Arg-191 in
NgoMIV), (Asp/Glu) (Asp-193 in NgoMIV), and Arg
(Arg-194 in NgoMIV) residues, which in NgoMIV are
involved in hydrogen bonds to the inner cytosine and guanine residues
(underlined) of the recognition sequence G
CCGGC. It is
tempting to conclude that these conserved (Arg/Lys), (Asp/Glu), and Arg
residues have a similar function in the other enzymes shown in Fig. 3
as their counterparts in NgoMIV.
Another region with almost 100% conservation in the alignment of Fig.
3 is around Glu-70 in the NgoMIV sequence. In the cocrystal structure this residue is located close to the active center of this
enzyme. Nearby is Gln-63 which is involved in a hydrogen bond to the
last base (underlined) of the recognition sequence G
CCGGC (39). The equivalent for this residue in
SsoII, PspGI, and EcoRII is a serine
residue, located in the middle of a sequence conserved among these
three enzymes, RXSRAGKXXE. This
sequence was identified by Reuter et al. (32) to be involved
in DNA binding by EcoRII (DNA-binding site II); it is
tempting to speculate that this is also true for the other enzymes
whose sequence is shown in the alignment of Fig. 3.
Mutational Analysis of Amino Acid Residues in DNA
Binding and Cleavage--
Based on the multiple sequence alignment
shown in Fig. 3, Arg-116, Arg-117, Arg-119, and Lys-122 as well as
Arg-186 and Arg-188 are candidates for amino acid residues involved in
DNA binding and recognition by SsoII, whereas Glu-125,
Asp-160, Lys-182, Glu-191, and/or Glu-195 could be responsible for DNA
cleavage. These residues were subjected to a mutational analysis. In
addition, Glu-187, Glu-233, and Lys-235 were included in this analysis:
Glu-187, because it is also a well conserved amino acid residue (Fig.
3); Glu-233 and Lys-235 as alternative candidate amino acid residues to
be involved in catalysis (these residues are part of a variant PD ... (D/E)XK motif:
Pro-Glu194 ...
Glu233-Asn-Lys235).
The variants carrying an alanine substitution in place of the wild type
amino acid residue were produced by site-directed mutagenesis, purified
to homogeneity, and analyzed with respect to their DNA binding and
cleavage activity.
DNA binding of the variants was analyzed by gel electrophoretic
mobility shift assays using oligo US/LS-20b in the presence of
Ca2+. Under these conditions SsoII binds
specifically to DNA containing a recognition site, whereas in the
absence of Ca2+ there is no specific binding, as multiple
band shifts are observed with a PCR
fragment,3 similarly as
reported for EcoRV (52). Fig.
4 shows the results of the gel shift
experiments with oligo US/LS-20b; the variants R116A, R117A, R119A,
R186A, and R188A show no or little DNA binding; the K122A,
E125A, D160A, and E187A variants show reduced DNA binding; and the
K182A, E191A, E195A, E233A, and K235A display a very similar affinity
for DNA as the wild type enzyme (Fig. 4 and Table
I), which was determined in several
titrations to be 40 ± 10 nM (data not shown). The
inability of some variants to bind to DNA specifically is not due to an
aberrant folding of the variants, because it was demonstrated that
these variants have an identical circular dichroism spectrum as the
wild type enzyme (data not shown).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
Electrophoretic mobility shift analysis of
SsoII and its variants. 50 nM
SsoII or its variants were incubated with 100 nM
32P-labeled double-stranded d(GCTGCCACCCTGGGTCTAAC). DNA
bound and unbound SsoII species were separated by
electrophoresis and subsequently analyzed using an instant imager.
wt, wild type.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Relative DNA cleavage and binding activity of SsoII variants with
alanine substitutions at positions of presumptive functional
importance
Cleavage activity was determined by performing cleavage experiments
with 100 nM 32P-labeled 325-bp PCR product
containing one recognition site (GCCTGGG) and
25 nM wild type (wt) or mutant SsoII at 37 °C
for 60 min. kapp values were calculated by measuring
the initial velocity of cleavage. A value of 0.15 ± 0.02 min 1 was obtained for the wild type enzyme. Binding activity
was determined using electrophoretic mobility shift assays by
incubating 100 nM 32P-labeled double-stranded
d(GCTGCCACCCTGGGTCTAAC) with increasing
concentrations of SsoII or its variants. The binding
isotherms were evaluated in terms of Kd values.
|
|
DNA cleavage by the variants was analyzed using a 325-bp PCR product
with one SsoII recognition site (Fig.
5). As expected, the variants defective
in DNA binding in the presence of Ca2+, namely R116A,
R117A, R119A, R186A, and R188A, are completely inactive in DNA
cleavage. In addition, E125A, D160A, K182A, E187A, and E195A turned out
to be unable to cleave DNA, although they can interact with DNA in a
specific manner. Detailed kinetic experiments carried out over more
extended incubation times demonstrated a residual DNA cleavage activity
only for the E195A variant in the range of 2% of the wild type
cleavage activity (Fig. 6 and Table I).
The small but nevertheless detectable activity of the E195A variant
suggested to us that Glu-191 could partially "rescue" this mutant;
in particular in the alignment shown in Fig. 3 two restriction enzymes
do not have a glutamic acid residue corresponding to Glu-195 but
instead only one corresponding to Glu-191. We therefore produced the
double mutant E191Q/E195Q which turned out to be completely
inactive.4 It is important to
note that E191A, E233A, and K235A show largely unaltered DNA binding
and cleavage activity. This result could be interpreted to mean that
Glu-125, Asp-160, Lys-182, and Glu-195 have a direct catalytic function
and not, however, Glu-191, Glu-233, and Lys-235. The low activity of
the K122A variant could be due to the fact that Lys-122 is located
close to the cluster of Arg residues (Arg-116 to Arg-119) that are
essential for DNA binding and cleavage.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 5.
Cleavage of a 325-bp PCR product by
SsoII and its variants. 100 nM
32P-labeled 325-bp PCR product containing one recognition
site was incubated with 25 nM SsoII or its
variants for 15 min at 37 °C. Cleavage products were separated by
electrophoresis and analyzed using an instant imager. wt,
wild type.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 6.
Cleavage of a 325-bp PCR product by the
SsoII variant E195A. 100 nM
32P-labeled 325-bp PCR product containing one recognition
site was incubated with 25 nM SsoII variant
E195A. Aliquots were withdrawn at the time indicated and analyzed by
electrophoresis. Quantitative evaluation was performed using an instant
imager.
|
|
The results of our mutational analysis of the active site residues of
SsoII are in very good agreement with results obtained for
StyD4I, a very close relative of SsoII, which
differs only in 15 positions from SsoII, 13 of which are due
to an N-terminal extension of StyD4I (53). Siksnys and
colleagues5 have shown that
variants of StyD4I corresponding to the SsoII variants D160A, K182A, R186A, R188A and E195A behave very similarly to
the SsoII variants.
 |
DISCUSSION |
For a long time type II restriction endonucleases were considered
to be unrelated in evolution, with the exception of some obviously
homologous isoschizomers. Only after the determination of the crystal
structure of EcoRV (54) and the comparison with the crystal
structure of EcoRI (55, 56) did it become clear that there
is a structural similarity between different and seemingly unrelated
enzymes. Due to divergent evolution, different subtypes exist with
differences in quaternary structure, domain organization, and active
site architecture on the one side and mechanistic details on the other side.
The majority of type II restriction enzymes are homodimers that cleave
the DNA within or immediately adjacent to their recognition site and do
not depend on binding to a second copy of their recognition site for
maximum activity. However, some of them compose four identical
subunits. Like SfiI (the first type IIF enzyme discovered), Cfr10I and NgoMIV cooperate in the concerted
cleavage of two recognition sites (57-59). Others depend on an
effector site that must be occupied for efficient DNA cleavage (type
IIE, like NaeI and EcoRII); the DNA in the
effector site, however, is not cleaved simultaneously with the DNA in
the cleavage site (59).
When we started to study SsoII it was not clear whether it
is an orthodox type II restriction endonuclease or not, but we soon
noticed that it shares sequence similarity with bona fide type IIE (EcoRII) and type IIF (Cfr10I and
NgoMIV) enzymes in functionally relevant regions
(EcoRII (32), Cfr10I (36-38), and NgoMIV (39)), as shown in Fig. 3. Our analysis of the
quaternary structure of SsoII by analytical
ultracentrifugation and gel filtration presented here demonstrates that
it is a homodimer, in the absence as well as in the presence of DNA. In
this respect it behaves like an orthodox type II restriction
endonuclease or like a type IIE enzyme and not, however, like a type
IIF enzyme. The fact that SsoII, unlike EcoRII
(22, 60, 61), is not stimulated by a second site on a DNA substrate, as
shown here, excludes that it is a type IIE enzyme but rather an
orthodox type II restriction endonuclease.
The active site of SsoII and EcoRII has not yet
been identified. The inspection of the SsoII amino acid
sequence yielded two candidate motifs for the active site: 1)
Pro-Glu194 ...
Glu233-Asn-Lys235, and 2)
(Pro)-Asp160 ... (Ser)-Ala-Lys182 ...
Glu195. No plausible candidates for motifs characteristic
for other nuclease families were detected. The first motif is unusual
inasmuch as it has a glutamic acid residue where so far only an
aspartic acid residue has been found. The mutational analysis indeed
shows that neither Glu-233 nor Lys-235 is essential for DNA cleavage, excluding that this sequence represents the catalytic center. The
second motif has been identified so far only as a variant (P)D ...
(D/E)XK motif in the type IIF restriction endonucleases Cfr10I (36-38) and NgoMIV (39). The alignment in
Fig. 3, however, demonstrates that this variant (P)D ...
(D/E)XK motif is embedded in a stretch of similar amino acid
residues common to 11 restriction enzymes (and three putative
restriction enzymes) that all have CCNGG, CCWGG, or CCGG in their
respective recognition sequences, among them EcoRII. The
mutational analysis of Asp-160, Lys-182, and Glu-195 in
SsoII demonstrates that this variant (P)D ...
(D/E)XK motif most likely is the true catalytic motif,
because Asp-160, Lys-182, and Glu-195 were found in the present study
to be essential for cleavage.
It can be expected that the sequence homologies apparent in the
sequence alignment (Fig. 3) reflect structural homologies, which should
manifest themselves in a secondary structure similar to that of
NgoMIV observed in the cocrystal structure of
NgoMIV (39). Indeed, a secondary structure prediction
carried out for SsoII and, for comparison, also for
EcoRII (Fig. 7) shows that in
the region of interest (SsoII, amino acids 123-232;
EcoRII, amino acids 270-370) there is a close
correspondence of secondary structure elements between
SsoII, EcoRII, and NgoMIV (as deduced from the cocrystal structure). As shown in Fig.
8, the structural core, which is
characteristic for many type II restriction endonucleases (7, 8, 62),
is likely to be also present in SsoII and EcoRII.
Projected onto this structural core, the presumptive functionally important amino acid residues are found in similar locations as observed in NgoMIV, if one takes into account that the
borders of individual secondary structure elements are not easily
predicted.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Secondary structure prediction for
SsoII and EcoRII. Shown on
top is the secondary structure of NgoMIV, as
determined by crystallography of the NgoMIV-product complex.
Indicated in gray are secondary structure elements. Residues
indicated by circles or crosses are involved in
DNA binding or catalysis, respectively (demonstrated for
NgoMIV by the cocrystal structure, suggested for
SsoII and EcoRII by a mutational analysis and/or
by analogy to NgoMIV). Residue 61 in SsoII is
known to be involved in DNA binding based on a cross-link (15), and
residues 261-263/265 in EcoRII are in DNA-binding site I
(32).
|
|

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 8.
Comparison of the NgoMIV
cocrystal structure with an SsoII model. Shown is
a detail of the structure to illustrate the secondary structure
elements and amino acid residues involved in DNA recognition
(R116, R117, R119, K122, R186, E187, and
R188) and cleavage (E125, D160, K182, E191, and
E195). In the SsoII model the position of
Arg-116, Arg-117, and Arg-119 are indicated by balls to
demonstrate that their side chain positions cannot be predicted
reliably. The underlined cytosine and guanine residues of
the recognition sequence (GCCGGC for NgoMIV and
CCNGG for SsoII) are
highlighted.
|
|
The quality of the multiple sequence alignment and of the secondary
structure prediction suggests that it should be possible to model the
core structural elements of SsoII using the
NgoMIV structure as a template (39). For that purpose, the
SsoII sequence was manually threaded onto the
NgoMIV structure using multiple sequence alignment and
secondary structure prediction to superimpose conserved and therefore
presumably functionally important amino acid residues of the target and
the template. The final model of an SsoII monomer comprising
amino acid residues 115-257 was obtained after several cycles of
modeling and energy minimization. For the modeling of the complex, the
DNA of the NgoMIV-DNA complex was docked onto the modeled
SsoII monomer, the DNA expanded by a central A:T base pair
(to convert the NgoMIV recognition site, GCCGGC, into
an SsoII recognition site, CCNGG) and a second
SsoII monomer positioned on the DNA in a symmetrical
fashion. No attempts were made to refine the dimer interface, the
protein-DNA interface, and the structure of the DNA beyond the relief
of the most severe steric clashes, because we do not believe that this
is justified given the relatively low degree of sequence similarity
between SsoII and NgoMIV and the methodology
available. On the other hand we trust that the model is sufficiently
detailed to illustrate that the sequence alignment and the secondary
structure prediction can be translated into a structural model that
allows us to visualize how SsoII might interact with DNA
(Fig. 8). According to this model Arg-186, Glu-187, and Arg-188 as
their counterparts in NgoMIV are involved in base
recognition, whereas Arg-116, Arg-117, and Arg-119 seem to be in an
ideal position to interact with the region at the end of the
recognition sequence.
 |
CONCLUSIONS |
Our results allow concluding that SsoII, an orthodox
type II restriction enzyme, has a similar DNA-binding site and
catalytic center as the typical type IIF enzyme NgoMIV. The
pronounced sequence similarities between SsoII and
EcoRII, a typical IIE enzyme, suggest that one can extend
this conclusion also to this enzyme. This would imply that Arg-262,
Lys-263, Arg-265, Lys-268, Lys-328, and Arg-330 of EcoRII
are involved in DNA recognition, whereas Asp-299, Lys-324, and Glu-337
are responsible for DNA cleavage and, furthermore, that DNA-binding
site I identified by Reuter et al. (32) is the allosteric
effector site.
An important outcome of our study concerns the evolutionary
relationship of SsoII, EcoRII, and
NgoMIV as representatives of three subfamilies within the
family of type II restriction endonucleases. We suggest that some
members of these subfamilies share a not too distant common ancestor
(Fig. 9), which presumably was a
homodimeric enzyme (similar to SsoII). By acquisition of an
extra domain (as it is seen in NaeI (29)), a type IIE enzyme
like EcoRII was derived. Alternatively, by formation of a
new interface for protein-protein interaction, tetramerization was made
possible giving rise to representatives of type IIF enzymes like
Cfr10I and NgoMIV. We believe that this scenario
happened many times starting from a homodimeric restriction enzyme,
which led to different groups of type IIE and IIF enzymes (63, 64).
This explains why sequence similarities are sometimes more pronounced
between members of different subtypes of restriction enzymes than among
the members of a subtype. In this respect, SsoII
evolutionarily is more related to EcoRII and
Cfr10I or NgoMIV than EcoRII is to
NaeI (another type IIE enzyme).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 9.
Evolutionary tree for SsoII
and its homologues. The bar at the bottom
represents the evolutionary distance scale. The numbers at the
nodes indicate % bootstrap support of the individual
branching points. Evolutionary events resulting in developing novel
features by the type IIE (EcoRII) and type IIF
(NgoMIV) branches are indicated. Although the presented tree
is unrooted, the position of the root is inferred to be between the
SsoII/EcoRII branch and the type IIF
(NgoMIV) branch based on the analysis using sequences of
enzymes cleaving sequences different from CCXGG or CCGG as
an outgroup (6); J. M. Bujnicki, unpublished data.
|
|
 |
ACKNOWLEDGEMENTS |
We thank Dr. A. Karyagina for supplying the
SsoII overproducing strain and making available the sequence
information of MvaI; C. Conzelmann for preparation of
some of the variants; Dr. M. Reuter, M. Mücke, and Dr. V. Siksnys
for communicating unpublished results; and Dr. A. Jeltsch for critical
reading of the manuscript. The technical assistance of Nadine Thome is
gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by the Deutsche
Forschungsgemeinschaft Grant Pi 122/13-3, the Fonds der
Chemischen Industrie, and the Deutscher Akademischer Austauschdienst.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Institut für
Biochemie, Justus-Liebig-Universität, Heinrich-Buff-Ring 58, D-35392 Giessen, Germany. Tel.: 49-641-99-35402; Fax.:
49-641-99-35409; E-mail:
vera.pingoud@chemie.bio.uni-giessen.de.
Published, JBC Papers in Press, February 4, 2002, DOI 10.1074/jbc.M111625200
2
A. Karyagina, personal communication.
3
G. Stengel, unpublished data.
4
V. Pingoud, unpublished data.
5
V. Siksnys, personal communication.
 |
ABBREVIATIONS |
The abbreviation used is:
oligo, oligonucleotide.
 |
REFERENCES |
| 1.
|
Roberts, R. J.,
and Macelis, D.
(2001)
Nucleic Acids Res.
29,
268-269[Abstract/Free Full Text]
|
| 2.
|
Wilson, G. G.,
and Murray, N. E.
(1991)
Annu. Rev. Genet.
25,
585-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Heitman, J.
(1993)
in
Genetic Engineering (NY)
(Setlow, J. K., ed), Vol. 15
, pp. 57-108, Plenum Press, New York
|
| 4.
|
Jeltsch, A.,
Kröger, M.,
and Pingoud, A.
(1995)
Gene (Amst.)
160,
7-16[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Bujnicki, J. M.,
and Rychlewski, L.
(2001)
Gene (Amst.)
267,
183-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Bujnicki, J. M.,
and Rychlewski, L.
(2001)
J. Mol. Microbiol. Biotechnol.
3,
69-72[Medline]
[Order article via Infotrieve]
|
| 7.
|
Kovall, R. A.,
and Matthews, B. W.
(1999)
Curr. Opin. Chem. Biol.
3,
578-583[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Pingoud, A.,
and Jeltsch, A.
(2001)
Nucleic Acids Res.
29,
3705-3727[Abstract/Free Full Text]
|
| 9.
|
Sapranauskas, R.,
Sasnauskas, G.,
Lagunavicius, A.,
Vilkaitis, G.,
Lubys, A.,
and Siksnys, V.
(2000)
J. Biol. Chem.
275,
30878-30885[Abstract/Free Full Text]
|
| 10.
|
Aravind, L.,
Makarova, K. S.,
and Koonin, E. V.
(2000)
Nucleic Acids Res.
28,
3417-3432[Abstract/Free Full Text]
|
| 11.
|
Bujnicki, J. M.,
Radlinska, M.,
and Rychlewski, L.
(2001)
Trends Biochem. Sci.
26,
9-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Kubareva, E. A.,
Petrauskene, O. V.,
Karyagina, A. S.,
Tashlitsky, V. N.,
Nikolskaya, I. I.,
and Gromova, E. S.
(1992)
Nucleic Acids Res.
20,
4533-4538[Abstract/Free Full Text]
|
| 13.
|
Petrauskene, O. V.,
Schmidt, S.,
Karyagina, A. S.,
Nikolskaya, I. I.,
Gromova, E. S.,
and Cech, D.
(1995)
Nucleic Acids Res.
23,
2192-2197[Abstract/Free Full Text]
|
| 14.
|
Sheflyan, G. Y.,
Kubareva, E. A.,
Kuznetsova, S. A.,
Karyagina, A. S.,
Nikolskaya, I. I.,
Gromova, E. S.,
and Shabarova, Z. A.
(1996)
FEBS Lett.
390,
307-310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Kubareva, E. A.,
Thole, H.,
Karyagina, A. S.,
Oretskaya, T. S.,
Pingoud, A.,
and Pingoud, V.
(2000)
Nucleic Acids Res.
28,
1085-1091[Abstract/Free Full Text]
|
| 16.
|
Pingoud, A.,
and Jeltsch, A.
(1997)
Eur. J. Biochem.
246,
1-22[Medline]
[Order article via Infotrieve]
|
| 17.
|
Karyagina, A. S.,
Lunin, V. G.,
Degtyarenko, K. N.,
Uvarov, V. Y.,
and Nikolskaya, I. I.
(1993)
Gene (Amst.)
124,
13-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Nikolskaya, I. I.,
Karpetz, L. Z.,
Kartashova, M.,
Lopatina, N. G.,
Skripkin, E. A.,
Suchkov, S. V.,
Uporova, T. M.,
Gruber, I. M.,
and Debov, S. S.
(1983)
Mol. Gen. Mikrobiol. Virusol.
12,
5-10[Medline]
[Order article via Infotrieve]
|
| 19.
|
Krüger, D. H.,
Kupper, D.,
Meisel, A.,
Reuter, M.,
and Schroeder, C.
(1995)
FEMS Microbiol. Rev.
17,
177-184[Medline]
[Order article via Infotrieve]
|
| 20.
|
Kossykh, V.,
Repyk, A.,
Kaliman, A.,
and Buryanov, Y.
(1989)
Biochim. Biophys. Acta
1009,
290-292[Medline]
[Order article via Infotrieve]
|
| 21.
|
Bhagwat, A. S.,
Johnson, B.,
Weule, K.,
and Roberts, R. J.
(1990)
J. Biol. Chem.
265,
767-773[Abstract/Free Full Text]
|
| 22.
|
Krüger, D. H.,
Barcak, G. J.,
Reuter, M.,
and Smith, H. O.
(1988)
Nucleic Acids Res.
16,
3997-4008[Abstract/Free Full Text]
|
| 23.
|
Pein, C. D.,
Reuter, M.,
Cech, D.,
and Krüger, D. H.
(1989)
FEBS Lett.
245,
141-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Pein, C. D.,
Reuter, M.,
Meisel, A.,
Cech, D.,
and Krüger, D. H.
(1991)
Nucleic Acids Res.
19,
5139-5142[Abstract/Free Full Text]
|
| 25.
|
Petrauskene, O. V.,
Kubareva, E. A.,
Gromova, E. S.,
and Shabarova, Z. A.
(1992)
Eur. J. Biochem.
208,
617-622[Medline]
[Order article via Infotrieve]
|
| 26.
|
Conrad, M.,
and Topal, M. D.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
9707-9711[Abstract/Free Full Text]
|
| 27.
|
Yang, C. C.,
and Topal, M. D.
(1992)
Biochemistry
31,
9657-9664[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Huai, Q.,
Colandene, J. D.,
Chen, Y.,
Luo, F.,
Zhao, Y.,
Topal, M. D.,
and Ke, H.
(2000)
EMBO J.
19,
3110-3118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Huai, Q.,
Colandene, J. D.,
Topal, M. D.,
and Ke, H.
(2001)
Nat. Struct. Biol.
8,
665-669[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bigger, C. H.,
Murray, K.,
and Murray, N. E.
(1973)
Nat. New Biol.
244,
7-10[Medline]
[Order article via Infotrieve]
|
| 31.
|
Morgan, R. D.,
Xiao, J. P.,
and Xu, S. Y.
(1998)
Appl. Environ. Microbiol.
64,
3669-3673[Abstract/Free Full Text]
|
| 32.
|
Reuter, M.,
Schneider-Mergener, J.,
Kupper, D.,
Meisel, A.,
Mackeldanz, P.,
Krüger, D. H.,
and Schroeder, C.
(1999)
J. Biol. Chem.
274,
5213-5221[Abstract/Free Full Text]
|
| 33.
|
Thielking, V.,
Selent, U.,
Köhler, E.,
Wolfes, H.,
Pieper, U.,
Geiger, R.,
Urbanke, C.,
Winkler, F. K.,
and Pingoud, A.
(1991)
Biochemistry
30,
6416-6422[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Anderson, J. E.
(1993)
Curr. Opin. Struct. Biol.
3,
24-30[Medline]
[Order article via Infotrieve]
|
| 35.
|
Stahl, F.,
Wende, W.,
Jeltsch, A.,
and Pingoud, A.
(1998)
Biol. Chem. Hoppe-Seyler
379,
467-473
|
| 36.
|
Bozic, D.,
Grazulis, S.,
Siksnys, V.,
and Huber, R.
(1996)
J. Mol. Biol.
255,
176-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Skirgaila, R.,
Grazulis, S.,
Bozic, D.,
Huber, R.,
and Siksnys, V.
(1998)
J. Mol. Biol.
279,
473-481[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Siksnys, V.,
Skirgaila, R.,
Sasnauskas, G.,
Urbanke, C.,
Cherny, D.,
Grazulis, S.,
and Huber, R.
(1999)
J. Mol. Biol.
291,
1105-1118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Deibert, M.,
Grazulis, S.,
Sasnauskas, G.,
Siksnys, V.,
and Huber, R.
(2000)
Nat. Struct. Biol.
7,
792-799[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kirsch, R. D.,
and Joly, E.
(1998)
Nucleic Acids Res.
26,
1848-1850[Abstract/Free Full Text]
|
| 41.
|
Bujnicki, J. M.,
Elofsson, A.,
Fischer, D.,
and Rychlewski, L.
(2001)
Bioinformatics
17,
750-751[Abstract/Free Full Text]
|
| 42.
|
Lundstrom, J.,
Rychlewski, L.,
Bujnicki, J. M.,
and Elofsson, A.
(2001)
Protein Sci.
10,
2354-2362[Abstract/Free Full Text]
|
| 43.
|
Saitou, N.,
and Nei, M.
(1987)
Mol |